Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Synbiotics AB
AB
Active
Org 5565698965
Varvstorget 16, 234 40
Lomma
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 1999 · 27 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Synbiotics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
EBITDA
SEK millions
0M
-1M
-2M
-3M
-4M
2021: -3M
-3M
2021
2022: -1M (+67% vs 2021)
-1M
+67%
2022
2023: -1M (0% vs 2022)
-1M
0%
2023
2024: -1M (0% vs 2023)
-1M
0%
2024
2025: 0M (+100% vs 2024)
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
573
562
563
513
515
Staff expenses
—
—
—
—
—
EBITDA
−310
−624
−1 079
−1 090
−2 632
Depreciation & amort.
—
−29
−219
−219
−225
EBIT
−310
−652
−1 298
−1 309
−2 857
Net financials
−312
1 385
299
1 802
4 581
Profit before tax
−621
733
−999
628
1 725
Tax
—
—
−0
−0
−0
Net profit
−621
733
−999
628
1 725
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
29 610
30 768
29 362
33 882
34 677
Equity
9 170
9 791
9 058
10 057
9 429
Long-term debt
19 916
19 916
20 246
0
0
Short-term debt
524
1 060
58
23 825
25 249
Total debt
20 440
20 977
20 304
23 825
25 249
Financial ratios
5-year trend
EBITDA margin
−54,0 %
This company
15,8 %
Market median
This company
Market median
442% below market
2021
2025
Equity ratio
31,0 %
This company
38,2 %
Market median
This company
Market median
19% below market
2021
2025
Return on equity
−6,8 %
This company
18,4 %
Market median
This company
Market median
137% below market
2021
2025
Net profit margin
−108,3 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2021
2025
Asset turnover
0,02×
This company
1,12×
Market median
This company
Market median
98% below market
2021
2025
Debt / equity
2,23×
This company
0,62×
Market median
This company
Market median
260% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Synbiotics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
